journal article·2018-07

A hematoporphyrin and indocyanine green co-delivery system with NIR triggered-controllable photoactivities for photodynamic therapy

Ziying Li, Tingting Lv, Yingying Zhang, Liang Xu, Lu Zhang, Xiuying Wang, Haijun Chen, Yu Gao

Dyes and Pigments· Volume 154
Publisher page

Abstract

Abstract Photodynamic therapy (PDT) was hindered by the poor water solubility and long-enduring photoactivities of photosensitizers. Here, we developed a novel controllable photodynamic agent CPHI based on β-cyclodextrin modified polyamidoamine (PAMAM) dendrimer (CP) co-delivery of indocyanine green (ICG) and hematoporphyrin (HP). The CPHI possessed appropriate particle sizes and zeta potentials, considerable photostability, and NIR-triggered release property. The fluorescence of HP could be quenched by ICG when HP and ICG were co-loaded inside the CP, and the quenching efficiency was related with the weight ratio of HP and ICG. When the feeding weight proportion of HP and ICG is 1/10, the fluorescence of HP was quenched by 87.3% in CPHI. Under 808 nm laser irradiation, the ICG in CP was degraded, and the fluorescence of HP could recover. The recovered HP was capable of generating reactive oxygen species (ROS) for PDT with 606 nm laser irradiation. The cytotoxicity and cell apoptosis studies showed that CPHI could effectively induce MCF-7 cells apoptosis with PDT effects under 808/660 nm laser. These results suggested that CPHI could be an efficient cancer therapeutic agent for controllable PDT with low dark toxicity.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Photodynamic therapy for cancer10.1038/nrc1071 ↗
2. Photodynamic therapy in oncology: mechanisms and clinical use10.1093/jnci/85.6.443 ↗
3. Mitochondrial photodamage and PDT-induced apoptosis10.1016/S1011-1344(97)00127-9 ↗
4. Photodynamic therapy
5. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
6. Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy10.1111/j.1751-1097.1984.tb08871.x ↗
7. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications10.1111/j.1365-2818.2005.01471.x ↗
8. Controllable photodynamic therapy implemented by regulating singlet oxygen efficiency10.1002/advs.201700113 ↗
9. Near infrared-activated upconversion nanoprobes for sensitive endogenous Zn2+ detection and selective on-demand photodynamic therapy10.1021/acs.analchem.6b04548 ↗
10. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct10.1021/nn304872n ↗
11. A pH-activatable and aniline-substituted photosensitizer for near-infrared cancer theranostics10.1039/C5SC01721A ↗
12. Nanostructured phthalocyanine assemblies with protein-driven switchable photoactivities for biophotonic imaging and therapy10.1021/jacs.7b05916 ↗
13. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo10.1021/nn102722z ↗
14. Versatile photosensitizers for photodynamic therapy at infrared excitation10.1021/ja0700707 ↗
15. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics10.7150/thno.5284 ↗
16. Multifunctional nanocarriers for cell imaging, drug delivery, and near-IR photothermal therapy10.1021/la903893n ↗
17. Single-step assembly of DOX/ICG loaded lipid–polymer nanoparticles for highly effective chemo-photothermal combination therapy10.1021/nn400334y ↗
18. Near-infrared light-triggered drug release nanogels for combined photothermal-chemotherapy of cancer10.1039/C5BM00048C ↗
19. Photodynamic therapy of rat liver cancer: protection of the normal liver by indocyanine green10.1007/BF02773815 ↗
20. Photosensitizer cross-linked nano-micelle platform for multimodal imaging guided synergistic photothermal/photodynamic therapy10.1039/C6NR04835H ↗
21. Engineered nanoparticles for drug delivery in cancer therapy10.1002/anie.201403036 ↗
22. And TYO, prasad PN. Photosensitization of singlet oxygen via two-photon-excited fluorescence resonance energy transfer in a water-soluble dendrimer10.1021/cm047825i ↗
23. ChemInform abstract: dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P ↗
24. PAMAM dendrimer-based multifunctional conjugate for cancer Therapy: synthesis, characterization, and functionality10.1021/bm0506142 ↗
25. The influence of surface modification on the cytotoxicity of PAMAM dendrimers10.1016/S0378-5173(02)00623-3 ↗
26. Cyclodextrin drug Carrier systems10.1021/cr970025p ↗
27. Host-guest chemistry of dendrimer-cyclodextrin conjugates: selective encapsulations of guests within dendrimer or cyclodextrin cavities revealed by NOE NMR techniques10.1021/jp3062916 ↗
28. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation
29. A fluorescence study of hematoporphyrin10.1366/000370273774333137 ↗
30. Long-range resonance energy transfer in molecular systems10.1146/annurev.physchem.54.011002.103746 ↗
31. FRET quenching of photosensitizer singlet oxygen generation10.1021/jp810324v ↗
32. Effect of surface properties on nanoparticle–cell interactions10.1002/smll.200901158 ↗
33. Improvement of therapeutic effects by laser irradiation technique in photodynamic therapy (PDT) laser system10.1016/j.pdpdt.2011.03.124 ↗
34. Analysis of the combined effect of lasers of different wavelengths for PDT outcome using 600, 630, and 660 nm10.1002/lapl.201110003 ↗
35. Roles of reactive oxygen species in monocyte activation induced by photochemical reactions during photodynamic therapy10.1163/156855701321138932 ↗
36. 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy10.3109/10715761003709802 ↗
37. The antioxidant role of a reagent, 2',7'-dichlorodihydrofluorescin diacetate, detecting reactive-oxygen species and blocking the induction of heme oxygenase-1 and preventing cytotoxicity10.1093/jb/mvj187 ↗
38. Detection of reactive oxygen species (ROS) by the oxidant-sensing probe 2',7'-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 793710.1016/j.bbrc.2010.06.006 ↗
39. Inhibition of cellular DNA synthesis and lack of antileukemic activity by non-photoactivated hematoporphyrin derivative10.1177/030089168106700304 ↗
40. A comparative study of cell killing effect on different stages of cell cycle in Hela by HPD plus laser irradiation
41. Photodynamic hyperthermal therapy with indocyanine green (ICG) induces apoptosis and cell cycle arrest in B16F10 murine melanoma cells10.1292/jvms.11-0464 ↗